Biosenta Inc.
ZRO
CNSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -95.65% | 2,200.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -95.65% | 2,200.00% | |||
| Cost of Revenue | -100.00% | 1,500.00% | |||
| Gross Profit | -100.00% | 600.00% | |||
| SG&A Expenses | 17.88% | 18.66% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.01% | 15.80% | |||
| Operating Income | -15.11% | -14.75% | |||
| Income Before Tax | -51.78% | 11.11% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -51.78% | 11.11% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -51.78% | 11.11% | |||
| EBIT | -15.11% | -14.75% | |||
| EBITDA | -15.13% | -14.78% | |||
| EPS Basic | -191.38% | 10.77% | |||
| Normalized Basic EPS | -193.06% | 11.11% | |||
| EPS Diluted | -191.38% | 10.77% | |||
| Normalized Diluted EPS | -193.06% | 11.11% | |||
| Average Basic Shares Outstanding | -48.00% | 0.00% | |||
| Average Diluted Shares Outstanding | -48.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||